Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months
Clinical trial NCT03032419 · COMPLETED
Trial details
- NCT number
- NCT03032419
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2017-09-21
- Enrollment
- 1002
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.